In addition, UDCA might exert immunomodulatory activity through blocking Treg cell differentiation and activation in tumor-bearing hosts by TGF-β degradation, enhancing anti-tumor immunity (Shen et al., 2022). The gene discussed is TGFB1; the disease is neoplasm.